FDA Safety Alert: Drug to Treat Ulcerative Colitis and Arthritis May Increase the Risk of Blood Clots and Death with Higher Dose
29 Jul, 2019 | 20:19h | UTCFDA Drug Safety Communication: FDA approves Boxed Warning about increased risk of blood clots and death with higher dose of arthritis and ulcerative colitis medicine tofacitinib (Xeljanz, Xeljanz XR) – U.S. Food & Drug Administration (free)
Commentary: Boxed Warnings Added to Drug for Ulcerative Colitis, Arthritis – NEJM Journal Watch (free)